Parnassus Investments LLC Acquires 8,468 Shares of Cigna Group $CI

Parnassus Investments LLC increased its holdings in Cigna Group (NYSE:CI) by 2.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 335,611 shares of the health services provider’s stock after acquiring an additional 8,468 shares during the period. Parnassus Investments LLC’s holdings in Cigna Group were worth $92,370,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of CI. Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after purchasing an additional 36 shares during the last quarter. OLD National Bancorp IN lifted its holdings in shares of Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after acquiring an additional 37 shares during the last quarter. CYBER HORNET ETFs LLC lifted its holdings in shares of Cigna Group by 5.3% in the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock valued at $220,000 after acquiring an additional 40 shares during the last quarter. BNP Paribas lifted its holdings in shares of Cigna Group by 0.7% in the 4th quarter. BNP Paribas now owns 5,676 shares of the health services provider’s stock valued at $1,566,000 after acquiring an additional 40 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. lifted its holdings in shares of Cigna Group by 0.8% in the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock valued at $1,428,000 after acquiring an additional 41 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Down 0.4%

Shares of NYSE CI opened at $294.64 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $77.94 billion, a P/E ratio of 12.49, a PEG ratio of 1.14 and a beta of 0.28. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The firm has a 50-day simple moving average of $281.93 and a two-hundred day simple moving average of $277.87.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Analysts Set New Price Targets

A number of research analysts recently commented on CI shares. Truist Financial increased their price target on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, June 6th. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Sanford C. Bernstein increased their price target on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Finally, Cantor Fitzgerald increased their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.